PEX168
Sponsors
Jiangsu HengRui Medicine Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd., First Affiliated Hospital Xi'an Jiaotong University
Conditions
HealthyType 2 DiabetesType 2 Diabetes Mellitus
Phase 1
A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
CompletedNCT01965496
Start: 2012-03-31End: 2013-04-30Updated: 2013-10-18
A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
CompletedNCT01976858
Start: 2011-06-30End: 2011-12-31Updated: 2013-11-06
Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects
CompletedNCT02447601
Start: 2015-03-30End: 2015-08-11Updated: 2017-01-24
The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects
CompletedNCT02451527
Start: 2015-05-31End: 2016-07-31Updated: 2016-11-30
Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects
CompletedNCT02461914
Start: 2015-08-01End: 2016-07-13Updated: 2017-01-24
Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function
NCT02467790
Start: 2015-02-28End: 2016-05-31Target: 24Updated: 2016-01-26
Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects
CompletedNCT02472236
Start: 2015-06-08End: 2016-01-18Updated: 2017-01-24